Co-Occurring Disorders: Addiction and Mental Health

The Rule, Not the Exception

Among people seeking treatment for substance use disorders, the majority have at least one co-occurring mental health condition. This is not a coincidence or a statistical artifact — it reflects a deep and complex relationship between addiction and mental illness that has been documented in research for decades. Understanding this relationship is essential for effective treatment, because treating addiction without addressing co-occurring mental health conditions — or vice versa — produces significantly worse outcomes than treating both together.

The term "co-occurring disorders" (also called "dual diagnosis" or "comorbidity") refers to the simultaneous presence of a substance use disorder and one or more mental health conditions. The most common co-occurring conditions include depression, anxiety disorders, post-traumatic stress disorder (PTSD), bipolar disorder, attention-deficit/hyperactivity disorder (ADHD), and personality disorders.

How Common Are Co-Occurring Disorders?

The data on co-occurring disorders is striking. The National Survey on Drug Use and Health consistently finds that approximately half of people with a substance use disorder also have a mental health condition, and approximately half of people with a mental health condition also have a substance use disorder. The National Comorbidity Survey found that people with any mental health disorder are more than twice as likely to have a substance use disorder as people without mental health conditions.

The rates vary by specific condition. People with bipolar disorder have among the highest rates of co-occurring substance use disorders — studies suggest that 40–60 percent of people with bipolar disorder will develop a substance use disorder at some point in their lives. Rates are also very high for PTSD (30–50 percent), antisocial personality disorder (80–90 percent), and schizophrenia (40–50 percent). Depression and anxiety disorders are so common in people with addiction that they are almost the norm rather than the exception.

Why Do They Co-Occur? Three Models

The relationship between addiction and mental health disorders is complex, and researchers have proposed several models to explain it. In practice, all three models probably apply to different people and different combinations of conditions.

The Self-Medication Model: People with mental health conditions use substances to relieve their symptoms. A person with social anxiety disorder may drink to reduce anxiety in social situations. A person with depression may use stimulants to feel more energetic and motivated. A person with PTSD may use alcohol or opioids to numb the intrusive memories and hyperarousal that characterize the condition. This model has strong intuitive appeal and is supported by research showing that substance use often begins or escalates in the context of untreated mental health symptoms.

The Substance-Induced Model: Substance use causes or exacerbates mental health conditions. Chronic alcohol use is associated with depression and anxiety, both during active use and in withdrawal. Stimulant use can produce psychosis, paranoia, and anxiety. Cannabis use, particularly heavy use during adolescence, is associated with increased risk of psychotic disorders. In this model, the mental health condition is a consequence of the substance use rather than a cause of it.

The Common Factor Model: Both addiction and mental health conditions share common underlying causes — genetic vulnerabilities, neurobiological mechanisms, and environmental risk factors — that make a person susceptible to both. The high heritability of both addiction and many mental health conditions, and the overlap in the genetic variants associated with them, supports this model. Adverse childhood experiences, trauma, and chronic stress are risk factors for both addiction and mental health conditions, and may explain much of their co-occurrence.

The Challenge of Diagnosis

Diagnosing co-occurring disorders is clinically challenging because the symptoms of substance use and mental health conditions overlap significantly and can mask each other. Alcohol withdrawal can produce anxiety and depression that are indistinguishable from primary anxiety and depressive disorders. Stimulant intoxication can produce symptoms that resemble mania or psychosis. Opioid withdrawal can produce depression and anxiety.

For this reason, accurate diagnosis of co-occurring mental health conditions typically requires a period of abstinence — usually at least two to four weeks — to allow substance-induced symptoms to resolve. Symptoms that persist after this period are more likely to reflect a primary mental health condition rather than a substance-induced state.

This diagnostic challenge has historically led to underdiagnosis of co-occurring disorders. Treatment programs that focused exclusively on addiction often failed to identify and treat co-occurring mental health conditions, and mental health programs often failed to identify and treat co-occurring substance use disorders. The result was a "revolving door" of treatment — people would get sober, relapse when their untreated mental health symptoms became overwhelming, get sober again, and relapse again.

Integrated Treatment: The Evidence-Based Approach

The research on treatment outcomes for co-occurring disorders is clear: integrated treatment — in which both the substance use disorder and the mental health condition are treated simultaneously by the same treatment team — produces significantly better outcomes than sequential or parallel treatment (treating one condition first, then the other, or treating them in separate programs).

Integrated treatment typically includes a combination of medication management (for both the substance use disorder and the mental health condition), psychotherapy (particularly cognitive-behavioral therapy, which has been shown to be effective for both addiction and many mental health conditions), peer support, and case management. The specific combination depends on the individual's needs and the conditions being treated.

Medications play an important role in integrated treatment. Antidepressants, mood stabilizers, and anti-anxiety medications can reduce the mental health symptoms that drive substance use. Medications for addiction — including naltrexone, buprenorphine, and acamprosate — can reduce cravings and prevent relapse. The combination of medications targeting both conditions is often more effective than either alone.

Trauma and PTSD

The relationship between trauma, PTSD, and addiction deserves special attention because of its prevalence and its clinical significance. Research consistently shows that people with PTSD have dramatically elevated rates of substance use disorders — estimates range from 30 to 50 percent — and that the relationship is bidirectional: PTSD increases the risk of addiction, and addiction increases the risk of PTSD (partly because intoxication increases the risk of traumatic experiences).

The self-medication model is particularly relevant for PTSD and addiction. The hyperarousal, intrusive memories, and emotional numbing of PTSD are profoundly distressing, and substances — particularly alcohol and opioids — provide temporary relief. But substance use also interferes with the natural processing of traumatic memories, preventing the emotional resolution that is necessary for recovery from PTSD. The result is a cycle in which PTSD drives substance use, and substance use perpetuates PTSD.

Effective treatment for co-occurring PTSD and addiction requires addressing both conditions. Trauma-focused therapies — including Prolonged Exposure, Cognitive Processing Therapy, and EMDR — have been shown to be effective for PTSD even in people with active addiction, and treating PTSD reduces substance use. The old clinical wisdom that PTSD could not be treated until the person was stably sober has been largely abandoned in favor of integrated approaches that address both conditions simultaneously.

Recovery with Co-Occurring Disorders

Recovery from addiction is possible for people with co-occurring mental health conditions, but it typically requires more comprehensive and sustained treatment than recovery from addiction alone. People with co-occurring disorders are more likely to relapse, more likely to require multiple treatment episodes, and more likely to need ongoing support and medication management.

This does not mean that recovery is less achievable — it means that the path to recovery may be longer and more complex. Many people with co-occurring disorders achieve stable, long-term recovery with appropriate treatment and support. The key is integrated treatment that addresses both conditions, ongoing monitoring and adjustment of treatment as needed, and strong peer and social support.

For people in 12-step programs, co-occurring mental health conditions can sometimes create challenges. The traditional AA/NA culture has not always been welcoming to people who take psychiatric medications, and some members have discouraged the use of antidepressants or other medications as inconsistent with sobriety. This attitude is not supported by the official positions of AA or NA, both of which explicitly support the use of medications prescribed by physicians. People with co-occurring disorders should feel empowered to seek and accept appropriate medical treatment as part of their recovery.